Business Description
Telix Pharmaceuticals is an Australian biopharmaceutical company founded in 2015 and headquartered in Melbourne, specializing in medicines that use targeted radiation to diagnose and treat cancer. The company has multiple products already on the market alongside a broad pipeline of treatments in development, targeting cancers including prostate, kidney, brain, bladder, and bone. Telix operates across Australia, North America, Europe, and other international markets, supported by partnerships with leading medical institutions.
